Apple stock price climbs as AirTag refresh drops and earnings loom

Apple stock price climbs as AirTag refresh drops and earnings loom

New York, Jan 27, 2026, 16:14 EST — Trading continues after-hours.

Apple shares climbed Tuesday, boosted by early buying ahead of the iPhone giant’s upcoming quarterly earnings and a new AirTag release.

The timing couldn’t be more awkward. U.S. stocks sit close to record highs, the Federal Reserve is in the midst of a meeting, and investors are facing a heavy slate of megacap earnings reports.

Apple’s earnings are crucial as they test two key drivers behind the stock’s long rally: demand for the iPhone and the expansion of its services segment. The latter, which covers the App Store, iCloud, and payments, remains Apple’s more profitable division.

Apple (AAPL.O) climbed roughly 1.1%, closing near $258.31 as the regular session wrapped up, with shares fluctuating between $256.08 and $261.93 earlier. The tech giant holds a market cap around $3.0 trillion and finished Monday at $255.41. (Apple Investor Relations)

On Monday, Apple unveiled an updated AirTag featuring a longer Bluetooth range, a louder speaker, and a second-generation Ultra Wideband chip. The company claimed this upgrade boosts Precision Finding—the Find My feature that provides on-screen directional guidance—by as much as 50%, all while maintaining the price at $29 per tag and $99 for a four-pack. (Apple)

JPMorgan bumped its price target on Apple shares to $315 from $305, maintaining an Overweight rating. The firm highlighted strong demand for the iPhone 17 lineup and noted that Apple’s scale and supplier deals should help offset margin pressures caused by rising memory costs. (Investing)

Jefferies took a different tack, cutting its price target to $276.47 from $283.36 but kept its Hold rating intact. Analyst Edison Lee flagged weaker momentum in services and referenced Sensor Tower data revealing App Store revenue growth of about 7% in the December quarter. (Investing)

Morgan Stanley took a cautious stance on Apple’s short-term trading outlook. Analyst Erik Woodring suggested the stock might “trade sideways to modestly lower after earnings,” regardless of whether iPhone demand beats expectations. (TheStreet)

The S&P 500 reached a new high on Tuesday, while the Nasdaq surged to its best level in three months, led by Apple and other big tech stocks. The Federal Reserve kicked off a two-day policy meeting, with traders focused on Wednesday’s statement for hints on interest rate moves. (Reuters)

The bar isn’t set low. Should Apple’s guidance signal weaker demand in China, a slowdown in services, or greater margin pressure than expected, the recent rally could unravel quickly.

Apple’s fiscal first-quarter results come out Thursday, with a conference call set for 5 p.m. ET. Investors will be watching closely for fresh guidance and any change in how management talks about iPhone sales, services growth, and spending on new AI-driven features. (Apple)

Stock Market Today

  • CSPC Pharmaceutical Group Shares Surge 129%, DCF Analysis Suggests Undervaluation
    January 27, 2026, 5:51 PM EST. CSPC Pharmaceutical Group's stock soared 129.2% over the past year, closing recently at HK$9.94. The company has outpaced many in the Hong Kong pharmaceuticals sector, drawing investor attention. A Discounted Cash Flow (DCF) valuation, which estimates a company's future cash flow value today, places CSPC's intrinsic worth at HK$16.55 per share, indicating a 39.9% discount to its current price. This suggests the stock may still be undervalued despite its recent rally. CSPC's latest annual free cash flow stands at CN¥4,038.3 million, projected to rise to CN¥7,829 million by 2030. Investors focused on value may find CSPC attractive after evaluating these fundamentals.
Microsoft stock pops 2% as Maia 200 AI chip news sets up MSFT earnings day
Previous Story

Microsoft stock pops 2% as Maia 200 AI chip news sets up MSFT earnings day

Micron stock jumps after $24 billion Singapore fab plan; MU investors turn to pricing and capex
Next Story

Micron stock jumps after $24 billion Singapore fab plan; MU investors turn to pricing and capex

Go toTop